SYNCROSOME is an innovative preclinical CRO with relevant disease models we offer robust drug efficacy data and high value interpretation to assist drug discovery companies in evaluating the potential of their therapeutic compounds. We provide more than 15 predictive animal models of pathology in CNS, cardiovascular, gastroenterology, respiratory and metabolic disorders.